NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 294 filers reported holding NEKTAR THERAPEUTICS in Q3 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $38,554,000 | -7.4% | 1,083,598 | -12.5% | 3.03% | -8.1% |
Q1 2019 | $41,613,000 | +11.6% | 1,238,489 | +9.2% | 3.29% | +6.0% |
Q4 2018 | $37,288,000 | -46.1% | 1,134,414 | 0.0% | 3.11% | -22.3% |
Q3 2018 | $69,154,000 | +24.8% | 1,134,414 | 0.0% | 4.00% | +33.3% |
Q2 2018 | $55,393,000 | -22.0% | 1,134,414 | +69.7% | 3.00% | -30.3% |
Q1 2018 | $71,034,000 | -13.0% | 668,492 | -51.1% | 4.31% | -20.1% |
Q4 2017 | $81,647,000 | +49.6% | 1,367,171 | -39.9% | 5.39% | +64.9% |
Q3 2017 | $54,592,000 | -0.7% | 2,274,661 | -19.1% | 3.27% | +4.2% |
Q2 2017 | $54,957,000 | -20.3% | 2,811,092 | -4.3% | 3.14% | -20.3% |
Q1 2017 | $68,937,000 | +42.4% | 2,937,255 | -25.5% | 3.93% | +16.9% |
Q4 2016 | $48,401,000 | -0.5% | 3,944,692 | +39.3% | 3.36% | +2.6% |
Q3 2016 | $48,665,000 | -5.0% | 2,832,636 | -21.3% | 3.28% | -0.8% |
Q2 2016 | $51,207,000 | +5.9% | 3,598,554 | +2.3% | 3.31% | -1.0% |
Q1 2016 | $48,359,000 | +83.5% | 3,517,011 | +124.9% | 3.34% | +283.7% |
Q4 2015 | $26,351,000 | – | 1,563,862 | – | 0.87% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Strong Tower Advisory Services | 404,972 | $6,913,000 | 4.02% |
GREAT POINT PARTNERS LLC | 504,691 | $9,064,000 | 2.11% |
Camber Capital Management LP | 3,750,000 | $67,350,000 | 2.07% |
ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,901,000 | 1.50% |
Rhenman & Partners Asset Management AB | 950,000 | $17,062,000 | 1.20% |
MAVERICK CAPITAL LTD | 5,838,426 | $104,858,000 | 1.06% |
Birchview Capital, LP | 72,000 | $1,293,000 | 0.88% |
Bellevue Group AG | 4,594,656 | $82,519,000 | 0.84% |
CM Management, LLC | 50,000 | $898,000 | 0.67% |
Duquesne Family Office | 1,000,000 | $17,960,000 | 0.58% |